Breaking

Moldova says Russia helped pro-Moscow MP flee long jail sentence
UAE court sentences 3 people to death in killing of Israeli-Moldovan rabbi Zvi Kogan
Prince Andrew accuser Virginia Giuffre says she’s dying after a car crash with a school bus
Britain’s second-largest city declares ‘major incident’ as 17,000 tons of uncollected garbage left on streets
US citizen detained in Belarus accused of sneaking into country on cargo train
Chinese military says it’s launched joint army, naval and rocket force drills around Taiwan in ‘stern warning’
Israeli strike kills three in Beirut in test of fragile ceasefire with Hezbollah
Burst gas pipe sparks colossal fire in Malaysia

Home
Features
- View All On Demos
Buy Now
Search for:

Investing

Clinical trial data shows RAD 101 detects Brain Metastases

February 10, 2025

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

CONNEQT Launches Apple Health Integration on iPhone

Gold Price Hits New Record, Breaking US$3,100 for First Time

Crypto Market Recap: Strategy, MetaPlanet Buy the Dip, Hut 8 Makes Deal with Trump Brothers

Categories
- Business (150)
- Investing (451)
- Stocks (175)
- World (538)

Disclaimer: thevoiceofthoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 thevoiceofthoughts.com | All Rights Reserved

Top

Type above and press Enter to search. Press Esc to cancel.